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I read with interest the recent article entitled ‘‘Association
of insertion/deletion polymorphism of ACE gene and Alzhei-
mer’s disease in Egyptian patients’’ by Hassanin et al. [1].
The authors investigated whether insertion/deletion polymor-
phism (dbSNP rs1799752) of the angiotensin converting
enzyme (EC 3.4.15.1; ACE; OMIM: 106180) was associated
with the risk of Alzheimer’s disease in Egyptian patients.
The authors reported that their ﬁndings support the hypothesis
of implication of the I (insertion) allele in the development of
Alzheimer’s disease [1]. However, I would like to make a few
comments about the study.
The Hardy–Weinberg equilibrium (HWE) predicts that in
a very large population with random mating, the allelic fre-
quencies will remain stable from generation to generation
provided there is no mutation, no migration and no natural
selection. The ‘‘STrengthening the REporting of Genetic
Association’’ study (STREGA) statement, strongly recom-
mended that authors in genetic association studies, state
whether HWE was considered [2].
I used the data present in Tables 1 and 2 of the article of
Hassanin et al. [1]. Hassanin and his colleagues stated that
the prevalence of the D (deletion) allele was equal to 0.95,
whereas by using the counting method, I estimated it as
0.9012 (= [2 · 73 + 9] ‚ (2 · 86) = 0.9012). Based on my
analysis, there is a signiﬁcant deviation between observedgenotypic frequencies with the expected genotypic frequencies
based on the HWE (v2 = 11.85, df = 1, P< 0.001).
We know that the above-mentioned disequilibrium might
not be explained by non-random mating (consanguineous
marriages mainly ﬁrst cousin marriages), mutation, natural
selection and migration. Considering that it has been sug-
gested that the deviation from the expected genotypic fre-
quencies based on the HWE may be a sign of genotyping
error [2], I think that during genotyping some kinds of
errors occurred. My suggestion might be conﬁrmed by com-
parison between the studies of Hassanin et al. [1] with other
reports from Egypt [3–7] on the prevalence of the D allele.
It should be noted that the study of Hassanin et al. [1]
showed a higher prevalence of the D allele (and alternatively
a lower prevalence of the I allele) compared with the other
studies [3–7].
On the other hand, Hassanin et al., reported that they did
not ﬁnd signiﬁcant difference in plasma ACE activities when
compared with different studied genotypes [1]. Based on the
data present in Table 3 of the above mentioned article, it seems
that plasma ACE activity in patients increased as a function of
the number of the D allele (P< 0.05) which is in accordance
with the previous reports indicating that the D allele has been
associated with a higher ACE activity in the serum and tissue
than the I allele [8] and the D allele leading to a higher expres-
sion of the ACE mRNA [9].
Finally, it seems that the reliability of the results of Hassa-
nin et al. [1] dramatically decreased and their ﬁndings must be
interpreted with caution.
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